Inhibition of equine S-adenohomocysteine hydrolase by 2′-deoxyadenosine.

The research investigates how the compounds 2′-deoxyadenosine and ARA serve as inhibitors for the enzyme S-adenosylhomocysteine hydrolase in horses, potentially impacting the conversion of adenosine and homocysteine to S-adenosylhomocysteine.

Understanding the Compounds

• 2′-Deoxyadenosine and 9-beta-D-arabinofuranosyladenine (ARA) are the primary compounds studied in this research.
• These compounds are identified as suicide inhibitors for the enzyme S-adenosylhomocysteine hydrolase in horses. In essence, they deter the functioning of the enzyme.

Observations from Initial Velocity Studies

• The researchers performed initial velocity studies of the synthetic reaction in which adenosine and homocysteine are converted to S-adenosylhomocysteine.
• The compounds adenine, adenosine 5′-triphosphate (ATP), and 9-beta-D-arabinofuranosyladenine (ARA) were found to be competitive inhibitors.
• This means that these compounds compete with the substrate for access to the enzyme’s active site, changing the enzyme’s ability to catalyze the reaction.
• The inhibition constants (Kis) for these compounds were determined to be 3.8 microM for adenine, 1.1 mM for ATP, and 30 microM for ARA.

Observations for 2′-Deoxyadenosine

• In contrast to the compounds mentioned above, the behavior of 2′-deoxyadenosine was different.
• This compound exhibited linear mixed inhibition which indicates that the compound binds to the enzyme in more than one way.
• This means that while the compound inhibits the enzyme’s function, it does not compete with the substrates for access to the enzyme’s active site.

Significance of the Studies

• The findings from this research provide insight into the functioning and inhibition of the S-adenosylhomocysteine hydrolase enzyme in horses.
• The knowledge of how these specific compounds act as inhibitors could potentially be used to regulate the activity of this enzyme in certain biological contexts.